Trial Outcomes & Findings for Stroke Swallowing Screening Tool Validation (NCT NCT01559649)

NCT ID: NCT01559649

Last Updated: 2016-07-19

Results Overview

Identify the combination of screenings items that provide the highest level of sensitivity in the identification of aspiration risk as measured by a videofluoroscopic swallow study (VFSS) in individuals admitted with suspected stroke.

Recruitment status

COMPLETED

Target enrollment

284 participants

Primary outcome timeframe

3 years

Results posted on

2016-07-19

Participant Flow

Chart review-1042 suspected stroke patients . Excluded-636 (h/o neuro disease, etc). Eligible-406. 137-declined, d/c before approaching. Consented-269. Screening completed-258 (11-unable to complete screening-d/c, unstable, etc). VFSS completed-256-250 analyzed (6 excluded from analysis-equipment failure, h/o dysphagia, etc.). RNs-15 participated.

Participant milestones

Participant milestones
Measure
Patients With Suspected Stroke
Veterans admitted to MEDVAMC with a suspected ischemic or hemorrhagic stroke recruited. Individuals with a history of neurological disease other than stroke, head and neck structural surgery, or history of dysphagia unrelated to the current stroke were excluded . Individuals who were obtunded, medically unstable, greater than 5 days post-admission were excluded. Patients with language or cognitive deficits who were judged by the attending neurologist to not have capacity to provide informed consent were eligible to participate, but they had to have an authorized representative available within 24 hours of admission to provide consent. Patients underwent swallowing screening and videofluoroscopic swallowing study (VFSS) to establish validity of screening items
Registered Nurses
Stroke ward nurses. The nurses administered and interpret the swallowing screening items. Speech pathologists made blinded, simultaneous interpretations of the screening items. Nurse and speech pathologist interpretation were used to establish nursing reliability.
Overall Study
STARTED
269
15
Overall Study
COMPLETED
250
9
Overall Study
NOT COMPLETED
19
6

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Stroke Swallowing Screening Tool Validation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Suspected Stroke
n=250 Participants
Veterans admitted to MEDVAMC with a suspected ischemic or hemorrhagic stroke.
Nurses
n=15 Participants
Registered nurses working on MEDVAMC stroke wards
Total
n=265 Participants
Total of all reporting groups
Age, Continuous
64 years
STANDARD_DEVIATION 9.5 • n=5 Participants
NA years
STANDARD_DEVIATION NA • n=7 Participants
NA years
STANDARD_DEVIATION NA • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
13 Participants
n=7 Participants
20 Participants
n=5 Participants
Sex: Female, Male
Male
243 Participants
n=5 Participants
2 Participants
n=7 Participants
245 Participants
n=5 Participants
Race/Ethnicity, Customized
White
98 participants
n=5 Participants
1 participants
n=7 Participants
99 participants
n=5 Participants
Race/Ethnicity, Customized
African American
120 participants
n=5 Participants
3 participants
n=7 Participants
123 participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic
32 participants
n=5 Participants
5 participants
n=7 Participants
37 participants
n=5 Participants
Race/Ethnicity, Customized
Asian
0 participants
n=5 Participants
6 participants
n=7 Participants
6 participants
n=5 Participants
Region of Enrollment
United States
250 participants
n=5 Participants
15 participants
n=7 Participants
265 participants
n=5 Participants
Previous History of Stroke
60 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
National Institutes of Health Stroke Scale score
2.6 units on a scale
STANDARD_DEVIATION 2.9 • n=5 Participants
NA units on a scale
STANDARD_DEVIATION NA • n=7 Participants
NA units on a scale
STANDARD_DEVIATION NA • n=5 Participants
Discharge Diagnosis
Imaging-confirmed stroke
140 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Discharge Diagnosis
Physician-confirmed stroke
16 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Discharge Diagnosis
Physician-confirmed TIA
49 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Discharge Diagnosis
Nonstroke/TIA
45 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Stroke Type
Ischemic
137 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Stroke Type
Hemorrhagic
3 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Stroke Location
right hemispheric damage
51 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Stroke Location
left hemispheric damage
50 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Stroke Location
bilateral
4 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants
Stroke Location
posterior circulation
35 participants
n=5 Participants
NA participants
n=7 Participants
NA participants
n=5 Participants

PRIMARY outcome

Timeframe: 3 years

Population: Nurses were not assessed for this outcome measure

Identify the combination of screenings items that provide the highest level of sensitivity in the identification of aspiration risk as measured by a videofluoroscopic swallow study (VFSS) in individuals admitted with suspected stroke.

Outcome measures

Outcome measures
Measure
Patients With Suspected Stroke
n=250 Participants
Veterans admitted to MEDVAMC with a suspected ischemic or hemorrhagic stroke
Registered Nurses
Stroke ward nurses.
Sensitivity of Screening Items
Age >70
37.9 percentage of agreement
Interval 20.7 to 57.7
Sensitivity of Screening Items
Lethargy
3.5 percentage of agreement
Interval 0.087 to 178.0
Sensitivity of Screening Items
Dysarthria
62.1 percentage of agreement
Interval 42.3 to 79.3
Sensitivity of Screening Items
Nonswallow wet voice
10.3 percentage of agreement
Interval 2.19 to 27.4
Sensitivity of Screening Items
Abnormal volitional cough
27.6 percentage of agreement
Interval 12.7 to 47.2
Sensitivity of Screening Items
Combined water swallow items
72.4 percentage of agreement
Interval 52.8 to 87.3
Sensitivity of Screening Items
Dysarthria or Water swallow item
86.2 percentage of agreement
Interval 68.3 to 96.1
Sensitivity of Screening Items
Age >70 or Dysarthria or Water swallow item
93.1 percentage of agreement
Interval 77.2 to 99.2

PRIMARY outcome

Timeframe: 3 years

Population: Nurses were not assessed for this outcome measure

Identify the combination of screenings items that provide the highest level of specificity in the identification of aspiration risk as measured by a videofluoroscopic swallow study (VFSS) in individuals admitted with suspected stroke.

Outcome measures

Outcome measures
Measure
Patients With Suspected Stroke
n=250 Participants
Veterans admitted to MEDVAMC with a suspected ischemic or hemorrhagic stroke
Registered Nurses
Stroke ward nurses.
Specificity of Screening Items
Age >70
82.8 percentage of agreement
Interval 77.2 to 87.5
Specificity of Screening Items
Lethargy
99.5 percentage of agreement
Interval 97.5 to 100.0
Specificity of Screening Items
Dysarthria
80.5 percentage of agreement
Interval 74.7 to 85.5
Specificity of Screening Items
Nonswallow wet voice
98.6 percentage of agreement
Interval 96.1 to 99.7
Specificity of Screening Items
Abnormal volitional cough
95.9 percentage of agreement
Interval 92.4 to 98.1
Specificity of Screening Items
Combined water swallow item
59.7 percentage of agreement
Interval 52.9 to 66.3
Specificity of Screening Items
Dysarthria or Water swallow item
49.3 percentage of agreement
Interval 42.6 to 56.1
Specificity of Screening Items
Age >70 or Dysarthria or Water swallow item
43.0 percentage of agreement
Interval 36.4 to 49.8

PRIMARY outcome

Timeframe: 3 years

Population: Nurses were not assessed for this outcome measure

Identify the combination of screenings items that provide the highest level of negative predictive value in the identification of aspiration risk as measured by a videofluoroscopic swallow study (VFSS) in individuals admitted with suspected stroke.

Outcome measures

Outcome measures
Measure
Patients With Suspected Stroke
n=250 Participants
Veterans admitted to MEDVAMC with a suspected ischemic or hemorrhagic stroke
Registered Nurses
Stroke ward nurses.
Negative Predictive Value of Screening Items
Combined water swallow itmes
94.3 percentage of agreement
Interval 89.1 to 97.5
Negative Predictive Value of Screening Items
Dysarthria or Water swallow item
96.5 percentage of agreement
Interval 91.2 to 99.0
Negative Predictive Value of Screening Items
Age >70
91.0 percentage of agreement
Interval 86.2 to 94.6
Negative Predictive Value of Screening Items
Lethargy
88.7 percentage of agreement
Interval 84.1 to 92.4
Negative Predictive Value of Screening Items
Dysarthria
94.2 percentage of agreement
Interval 89.8 to 97.1
Negative Predictive Value of Screening Items
Nonswallow wet voice
89.3 percentage of agreement
Interval 84.8 to 92.9
Negative Predictive Value of Screening Items
Abnormal volitional cough
91.0 percentage of agreement
Interval 86.6 to 94.3
Negative Predictive Value of Screening Items
Age >70 or Dysarthria or Water swallow item
97.9 percentage of agreement
Interval 92.7 to 99.7

SECONDARY outcome

Timeframe: 3 years

Determine if current stroke-ward staff nurses can accurately administer screening items.

Outcome measures

Outcome measures
Measure
Patients With Suspected Stroke
n=15 Participants
Veterans admitted to MEDVAMC with a suspected ischemic or hemorrhagic stroke
Registered Nurses
Stroke ward nurses.
Average Accuracy Rate for Nurse Administration for All Screening Procedures
98.33 percentage of accuracy
Interval 95.42 to 100.0

SECONDARY outcome

Timeframe: 3 years

Determine if stroke-ward staff nurses can make reliable inter-rater judgments of swallowing (e.g. cough after swallow, wet voice after swallow) and nonswallowing features (e.g. decreased volitional cough, dysarthria) historically used by SLPs to make judgments of aspiration.

Outcome measures

Outcome measures
Measure
Patients With Suspected Stroke
n=15 Participants
Veterans admitted to MEDVAMC with a suspected ischemic or hemorrhagic stroke
Registered Nurses
Stroke ward nurses.
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
Nonswallow wet voice
0.360 kappa
Interval -0.017 to 0.594
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
Lethargy
0.394 kappa
Interval -0.152 to 0.94
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
Dysarthria
0.717 kappa
Interval 0.667 to 0.754
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
Abnormal volitional cough
0.645 kappa
Interval 0.594 to 0.712
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
Cough after swallowing
0.911 kappa
Interval 0.824 to 0.997
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
Throat clear after swallowing
0.837 kappa
Interval 0.76 to 0.914
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
Wet voice after swallowing
0.727 kappa
Interval 0.567 to 0.888
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
Inability to continuously drink 90ml of water
0.911 kappa
Interval 0.788 to 1.0
Reliability of Nurse Interpretation of Each Screening Items and the Valid Combination of Items
1 minute wet voice
1.000 kappa
Interval 1.0 to 1.0

Adverse Events

Patients With Suspected Stroke

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Stephanie Daniels

Michael E. DeBakey VA Medical Center

Phone: 713-743-2570

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place